The latest closing stock price for C4 Therapeutics as of November 08, 2024 is 6.06.
An investor who bought $1,000 worth of C4 Therapeutics stock at the IPO in 2020 would have $-762 today, roughly -1 times their original investment - a -30.17% compound annual growth rate over 4 years.
The all-time high C4 Therapeutics stock closing price was 50.50 on September 23, 2021.
The C4 Therapeutics 52-week high stock price is 11.88, which is 96% above the current share price.
The C4 Therapeutics 52-week low stock price is 1.06, which is 82.5% below the current share price.
The average C4 Therapeutics stock price for the last 52 weeks is 5.98.
An investor who bought $1,000 worth of C4 Therapeutics stock at the IPO in 2020 would have $-762 today, roughly -1 times their original investment - a -30.17% compound annual growth rate over 4 years.
The all-time high C4 Therapeutics stock closing price was 50.50 on September 23, 2021.
The C4 Therapeutics 52-week high stock price is 11.88, which is 96% above the current share price.
The C4 Therapeutics 52-week low stock price is 1.06, which is 82.5% below the current share price.
The average C4 Therapeutics stock price for the last 52 weeks is 5.98.